Radiopharmaceuticals
Ended Awarded Last action
- Contract number
- 36C25226N0112
- Awardee
-
Cardinal Health 414, LLC UEI CWN9UGL3NCL9 Part of Cardinal Health, Inc.
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $30,815
Award facts
- Contract value 100% obligated
- $30,814.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$21,357 | |
| Original award | $52,172 |
About this award
Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. specializing in radiopharmaceutical manufacturing and distribution, was awarded a delivery order valued at $30,814.82 by Veterans Integrated Service Network 12 on October 1, 2025, for the supply of radiopharmaceuticals using Defense Enhancements Operations and Budget (DEOB) funds. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of March 25, 2026, and will be performed at the awardee's primary facility in Dublin, Ohio. This award carries no set-aside designation and represents a task order issued against a larger Indefinite Delivery Vehicle contract framework that Cardinal Health 414 maintains with VISN 12, enabling flexible procurement of time-sensitive nuclear medicine products essential for diagnostic imaging and therapeutic applications across the Veterans Affairs healthcare system.
Cardinal Health 414 holds established single-award Indefinite Delivery Contracts with VISN 12 and numerous other Veterans Integrated Service Networks, with ceiling values ranging up to several million dollars and performance periods extending through 2029 and 2030. The company's comprehensive radiopharmaceutical portfolio includes technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, and specialized therapeutic products such as Xofigo for prostate cancer treatment and Lymphoseek for diagnostic imaging. The firm's federal contracting activity reflects its critical role as a single-source supplier for certain proprietary radiopharmaceuticals, supported by Nuclear Regulatory Commission licensing and FDA approval compliance, as well as Department of Transportation certifications for radioactive materials transport.
Quick answers
Who was awarded contract 36C25226N0112?
36C25226N0112 was awarded to Cardinal Health 414, LLC by Veterans Integrated Service Network 12 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C25226N0112 worth?
The government has obligated $30,815 on 36C25226N0112.
Is contract 36C25226N0112 an order under another contract?
Yes. 36C25226N0112 is a delivery order under 36C25222D0056, an indefinite delivery contract.
Was contract 36C25226N0112 competed?
The extent of competition for 36C25226N0112 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award